JPRN-UMIN000021802招募中未知
Research for elucidating the resistance mechanism to RET tyrosine kinase inhibitors in patients with non-small-cell lung cancer harboring with RET fusion gene - Research for RET-TKI resistance in NSCLC harboring with RET fusion gene
Cancer Research Institute, Kanazawa University0 个研究点目标入组 30 人开始时间: 2016年4月12日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Having previously received alectinib 2.Patients whom an investigator deems ineligible for participation in this study for some other reason.
研究者
相似试验
已完成
不适用
A translational study on mechanism of resistance to PARP inhibitor in patients with breast cancer and gBRCA1/2 mutation (WJOG15321B)germline BRCA1/2 mutation-positive metastatic breast cancerJPRN-UMIN000046007West Japan Oncology Group60
招募中
不适用
Analysis of the mechanisms of acquired resistance to molecular-targeted therapy in lung cancer using liquid biopsy of circulating nucleotide acids and circulating tumor cellsung cancerJPRN-UMIN000031472agoya University Hospital40
尚未招募
不适用
Research on the mechanism of resistance to treatment of pituitary adenomaspituitary adenomaJPRN-UMIN000043863agoya university graduate school of medicine100
进行中（未招募）
1 期
MEchanisms of resitance in EGFR mutated nonpretreated advanced Lung cancer Receiving OSimErtibEUCTR2018-003218-42-FRCHU de Nantes66
进行中（未招募）
不适用
The effects of midazolam on the quality of postoperative recoveryperioperative resistance, anxietyMedDRA version: 14.1Level: LLTClassification code 10037935Term: Reaction anxietySystem Organ Class: 100000004873EUCTR2012-003680-21-NLErasmus MC